| Incyte Data to Be Highlighted in Four Rapid |
| @jameshebrew |
07/17/2026 5:15:01 PM |
| Incyte Presents Phase 1/2 Multidose Data for VGA039 |
| @Nugent1500 |
07/13/2026 8:15:18 AM |
| Incyte Completes Acquisition of Vega Therapeutics, a Wholly |
| @idronbes |
07/06/2026 12:46:32 PM |
| Incyte Announces Positive CHMP Opinion for Opzelura (ruxolitinib) |
| @ezblockchain |
06/26/2026 11:45:43 AM |
| Incyte Japan Announces Approval of Minjuvi (tafasitamab) in |
| @garg |
06/19/2026 6:15:02 AM |
| Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase |
| @SantoshAgarwal |
06/14/2026 8:45:18 PM |
| Incyte Announces New Positive Data at EHA 2026 |
| @Manish99 |
06/13/2026 3:15:07 PM |
| Results from Incytes Pivotal Phase 3 frontMIND Trial |
| @JR__101 |
06/13/2026 10:00:08 AM |
| Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results |
| @jpstocks303 |
06/04/2026 12:15:33 PM |
| Incytes Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi/Minjuvi) Combinat |
| @weedwebnyc |
05/30/2026 12:15:50 PM |
| Incyte gibt bekannt, dass mehr als 20 Abstrakte |
| @fandomfans |
05/13/2026 5:01:01 PM |
| Incyte annonce que plus de 20 rsums ont |
| @Financier2020 |
05/13/2026 5:00:50 PM |
| Incyte Announces More Than 20 Abstracts Accepted for |
| @Will |
05/12/2026 1:45:35 PM |
| Incyte annonce les donnes long terme sur |
| @the1stbarbarian |
05/07/2026 11:15:12 PM |
| Incyte gibt Langzeitdaten nach 24 Wochen aus der |
| @shubhamdhr |
05/07/2026 11:15:02 PM |
| Incyte Announces 24-Week Long-Term Data from Phase 3 |
| @Pbadhe2000 |
05/07/2026 1:01:22 PM |
| Incyte Reports Inducement Grants Under Nasdaq Listing Rule |
| @jagan9968 |
05/06/2026 8:50:03 PM |
| Incyte gibt die FDA-Zulassung von Jakafi XR (Ruxolitinib) |
| @Kenny |
05/03/2026 2:00:19 PM |
| Incyte annonce lautorisation par la FDA des comprims |
| @rgordon908 |
05/03/2026 2:00:08 PM |
| Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) |
| @tasindjamila |
05/01/2026 9:30:02 PM |
| ??????2026?????????(ASCO)??????????????3?????????????? April 22, 2026 6:39 AM |
| @lcraw2016 |
04/22/2026 10:45:22 AM |
| Incyte prsente de nouvelles donnes de phase III |
| @sophial |
04/22/2026 10:45:12 AM |
| Incyte prsentiert neue Phase-3-Daten zu Tafasitamab auf der |
| @Fuadshehadh |
04/22/2026 10:45:01 AM |
| Incyte annonce de nouvelles donnes positives de dernire |
| @HandyManz |
03/29/2026 6:00:07 PM |
| Incyte prsentiert neue positive 54-Wochen-Daten zu Povorcitinib bei |
| @Alanmills |
03/29/2026 5:15:08 PM |
| Incyte Announces New Positive 54-Week Late-Breaking Data for |
| @Hxkxj |
03/28/2026 7:15:18 PM |
| Incyte annonce des nominations au sein de sa |
| @AnonymousThinker |
03/25/2026 8:30:52 PM |
| Incyte verkndet Ernennung von Fhrungspersonal March 25, 2026 |
| @Cbp507 |
03/25/2026 8:00:12 PM |
| Incyte prsentera des donnes de dernire minute sur |
| @Rickrut1 |
03/20/2026 11:45:12 PM |
| Incyte wird auf der Jahrestagung 2026 der American |
| @TomS |
03/20/2026 11:45:01 PM |
| Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at |
| @rockymtnman |
03/20/2026 2:15:08 PM |
| Incyte meldet die Zulassung von Zynyz (Retifanlimab) durch |
| @twhammond |
03/07/2026 4:15:12 PM |
| Incyte annonce lautorisation par la Commission europenne de |
| @GoMotopia |
03/07/2026 4:15:02 PM |
| Incyte Announces the European Commission Approval of Zynyz |
| @lorensmoore |
03/06/2026 9:45:01 PM |
| Lilly's Olumiant (baricitinib) recommended by CHMP for approval |
| @gofohhug57 |
02/27/2026 1:15:20 PM |
| Incyte slips after Q4 profit miss despite strong |
| @ |
02/10/2026 4:00:45 PM |
| Incyte gibt positive CHMP-Stellungnahme zu Zynyz (Retifanlimab) fr |
| @Ishbal |
01/30/2026 9:00:18 PM |
| Incyte annonce un avis favorable du CHMP concernant |
| @ |
01/30/2026 8:45:07 PM |
| Incyte Announces Positive CHMP Opinion for Zynyz (retifanlimab) |
| @Baroth |
01/30/2026 2:30:08 PM |
| Think I'll start a position in INCY
|
| @jdwashington |
06/27/2025 12:39:38 AM |
| $INCY up and down but mostly up |
| @Monksdream |
09/14/2024 6:07:20 PM |
| David Gryska, Board Director, Chair of Audit Committee |
| @ |
08/27/2024 1:56:01 AM |
| Incy and Gern merger? |
| @ |
06/13/2024 2:22:17 PM |
| Ouch Ouch Ouch! |
| @ |
03/01/2022 8:54:44 AM |
| nice chart but meaningless. Your first sentence says |
| @BenGrady |
02/17/2021 5:39:14 PM |
| Long or short $INCYTE corp ? Move coming soon. |
| @jvsapu9728 |
07/02/2019 7:48:41 PM |
| Long or short $INCYTE corp ? Move coming soon. |
| @burill |
07/02/2019 7:48:39 PM |
| News: $INCY Incyte Announces Positive Results from a |
| @ |
06/15/2019 12:00:39 PM |
| News: $INCY Incyte Announces First Patient Treated in |
| @ |
01/22/2019 7:31:26 PM |
| $INCY invest 65.08 |
| @Yessyall |
10/08/2018 1:38:21 AM |
| Never late and it is very promising |
| @sidcorp2020 |
07/11/2018 11:51:15 PM |
| Not in, but wish would have bought several |
| @brokersanalysis |
07/11/2018 7:07:05 PM |
| $INCY Incyte (NASDAQ:$INCY)
2018 EPS Estimate: $0.41
2019 EPS Estimate: |
| @ |
07/07/2018 9:51:05 PM |
| Got lucky. Have been eyeing it more closely |
| @ |
04/06/2018 1:29:10 PM |
| Fantastic great sale, Kyle Dennis and |
| @ |
04/06/2018 1:09:45 PM |
| Sold @ $90.50 to take profits. Has moved |
| @ |
03/05/2018 7:47:53 PM |
| Back in $INCY @ $81.85. 52 week low. |
| @elk_l |
03/01/2018 3:13:30 PM |
| So glad sold @ $89.10 yesterday toward the |
| @ |
02/15/2018 2:38:12 PM |
| How Incytes Jakafi Performed in 3Q17 |
| @ |
01/10/2018 1:43:12 PM |
| Was thinking the same. Hope this will pass |
| @ |
01/09/2018 6:59:26 PM |
| Herve made it clear that being taken over |
| @brooke4green |
01/09/2018 6:04:51 PM |
| CEO interview: |
| @Cowboy |
01/09/2018 1:24:36 PM |
| FWIW:
Jim Cramer Advises His Viewers On Incyte And |
| @Nyrpcorp |
01/08/2018 1:40:35 PM |
| Incyte and Syros Announce Global Target Discovery and |
| @Januszek |
01/08/2018 1:30:23 PM |
| As long as they don't turn out like $KATX. |
| @ |
12/22/2017 9:53:22 PM |
| 3 Promising Cancer Immunotherapies to Watch in 2018 |
| @creativebiomart |
12/22/2017 3:32:38 PM |
| Biotech Pullback Makes Bargains Out Of Alexion, Flexion, |
| @watjohn |
11/29/2017 5:09:11 PM |
| In Incyte for the 1st time @ $99.25. |
| @ |
11/21/2017 3:04:23 PM |
| https://seekingalpha.com/article/4124190-bristol-myers-squibb-brings-ace-card-mi |
| @maria |
11/13/2017 2:21:18 PM |
| I have seen no evidence to support that |
| @eastjuntai |
10/25/2017 7:04:08 PM |
| $INCYs own PD-1 candidate (#msg-116696022) is apparently dead. |
| @knesset |
10/25/2017 4:02:32 PM |
| MGNX/$INCY deal is + for both, so far today. |
| @ |
10/25/2017 3:05:20 PM |
| Not so surprising....One expects a fairly high failure |
| @ |
08/01/2017 6:58:24 PM |
| They stopped some trials: |
| @ |
08/01/2017 6:53:00 PM |
| Let's see here; We've got a pipeline full |
| @Bhamrsingh |
08/01/2017 6:34:39 PM |
| http://www.mdedge.com/rheumatologynews/article/104503/rheumatoid-arthritis/baric |
| @elsieyoung |
04/17/2017 2:16:39 PM |
| FDA CRL on $INCY/LLY data re med for |
| @admin06 |
04/17/2017 12:01:49 PM |
| Baker Brothers selling all or a big chunk |
| @Patel1962 |
03/10/2017 11:42:10 PM |
| We join the S&P 500, which means index |
| @ |
02/24/2017 7:36:19 PM |
| they will partner w/ ? |
| @Davidamero |
02/15/2017 3:08:40 PM |
| This 10yr DCF valuation analyses implies Incyte $INCY |
| @mrowland |
02/13/2017 2:39:53 PM |
| (Good news for$ INCY)$GILDs Momelotinib goes 1-for-2 in |
| @ |
11/16/2016 10:26:48 PM |
| What's going on today?? |
| @jcostello1975 |
11/09/2016 2:56:23 PM |
| Incyte Corp fundamental analysis highlights shares are ~15% |
| @XAU |
10/31/2016 6:32:03 PM |
| Hello!? Hello?! |
| @Rbanihas |
08/23/2016 9:39:47 PM |